Search

You searched for "Moorfields"

437 results found

The work of BIPOSA

4 December 2023 | EYE - Paediatrics, EYE - Strabismus
The British and Irish Paediatric Ophthalmology and Strabismus Association (BIPOSA) was set up in 2008 to merge two streams of ophthalmology, namely the practice of paediatric ophthalmology and the practice of strabismus (to include refracting in children, and strabismus in...

Virtual ophthalmic conferences: learnings from the Covid-19 pandemic

3 April 2024 | | EYE - General
The Covid-19 pandemic was the catalyst for a number of paradigm shifts in numerous industries. The demand for proxies that follow social distancing measures created a hotbed for digital solutions and transitioned these to social convention. In the aftermath, the...

Eyes on Tomorrow podcast: “Desert Island Discs for ophthalmologists”

4 December 2024 | | EYE - Glaucoma, EYE - Cataract, EYE - Refractive, EYE - Cornea
What happens when an ophthalmologist and optometrist get chatting in a pub, over a couple of pints of Guinness, about how they could create something educational and entertaining for ophthalmologists and optometrists? The answer is the Eyes on Tomorrow podcast....

Report on ‘2024: Artificial Intelligence and the Eye’

3 June 2024 | | EYE - General
As the application of artificial intelligence (AI) is brought to the foray of clinical medicine, you can be forgiven for thinking that it is a relatively recent technology. However, researchers and computer scientists have been working on it for many...

Orbis UK partners with optometry podcast Beedie on Eyewear to spotlight global eye health

20 March 2026 | international, charity
International eye care charity Orbis UK has partnered with Beedie on Eyewear: The Podcast for its second season, highlighting the global problem of avoidable sight loss to audiences in the optical sector. Hosted by optometrist Beedie, the weekly podcast takes...

Using medical AI as ‘autopilot’ risks deskilling of clinicians, caution doctors and aviation safety experts

2 April 2026 | artificial intelligence, services, oculomics
As artificial intelligence (AI) becomes increasingly integrated into healthcare services, there are important lessons that the medical profession can learn from the aviation industry, which faced widespread loss of human skills after the adoption of autopilot. While calls for medicine...

Artificial intelligence could transform patient education in eyecare

17 April 2026 | artificial intelligence, public health, technology
A multilingual, voice-enabled chatbot helps patients access retinal detachment advice through personalised, real-time, clinically grounded conversations. From hospital leaflets to spoken answers in dozens of languages, new research from the University of East London (UEL) suggests artificial intelligence could dramatically...

Developments in retinal pigmentation measurement and the hopes of an equitable future

4 August 2025 | | EYE - Vitreo-Retinal, EYE - Imaging
Our AI & Oculomics co-editor, Nima Ghadiri, sat down with Abraham Olvera-Barrios from Moorfields and Anand Rajesh from the University of Washington to discuss their recent international study into retinal pigmentation and its wider clinical, technological and academic applications. Can...

Largest-ever UK survey of people with glaucoma launches

6 July 2026 | surveys, services
Landmark national study endorsed by leading eye health bodies aims to capture the experiences of 10,000 people and inform the future development of glaucoma services. Glaucoma UK has launched the National Patient Voices Survey, the largest survey of people affected...

Dissecting the green credentials of ophthalmology virtual clinics

1 August 2026
Since 2006, the NHS’ long-term plans have consistently advocated and resourced telemedicine. The current 10-year plan that was announced in 2019 aimed to cut face-to-face outpatient visits by one-third by 2024, by adopting digital consultations. The NHS plan calculates that...

First treatment for late-stage dry AMD rejected by UK drug regulator

17 February 2025 | AMD, geographic atrophy, Dry, macular society, Apellis, pharma
Leading sight loss charity the Macular Society has responded to the decision not to approve the first potential treatment for geographic atrophy (GA) or late stage dry aged-related macular degeneration. The decision is a significant setback for those affected by...

Pituitary tumours: why are they so often missed?

1 April 2017 | | EYE - Neuro-ophthalmology
Part 1: Introduction, historical background and Edinburgh connections (see also Part 2 and Part 3) Is there any ophthalmologist who has not missed a pituitary tumour? Hopefully this article will help those currently in practice to avoid such an embarrassment,...